Outcome of the Semibranch in Pararenal and Thoracoabdominal Aortic Pathologies. A Prospective, Multicentre Registry.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Muenster
About this trial
The goal of this registry is to evaluate the semibranch in branched endovascular aortic repair, which is a new tool in endovascular branched aortic repair.
Eligibility criteria
Qualifiers
18 years or older
Presence of pararenal or thoracoabdominal aortic pathology
Treatment planned a semibranch device branch from Artivion
Availability of the patients during the follow up period
Disqualifiers
Women of childbearing age
Patients under 18 years
Trial design
Treatments tested in this trial
- Semibranch CMD branched aortic stentgraft
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov